Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.
Paller, Amy S; Hong, Ying; Becker, Emily M; de Lucas, Raul; Paris, Maria; Zhang, Wendy; Zhang, Zuoshun; Barcellona, Claire; Maes, Peter; Fiorillo, Loretta.
Afiliação
  • Paller AS; Northwestern University Feinberg Medical School, Chicago, Illinois. Electronic address: apaller@northwestern.edu.
  • Hong Y; Celgene Corporation, Summit, New Jersey.
  • Becker EM; University of Texas Health Science Center-San Antonio, San Antonio, Texas.
  • de Lucas R; Hospital Universitario La Paz, Madrid, Spain.
  • Paris M; Celgene Corporation, Summit, New Jersey.
  • Zhang W; Celgene Corporation, Summit, New Jersey.
  • Zhang Z; Celgene Corporation, Summit, New Jersey.
  • Barcellona C; Celgene Corporation, Summit, New Jersey.
  • Maes P; Celgene Corporation, Summit, New Jersey.
  • Fiorillo L; Pediatric Department, University of Alberta, Edmonton, Canada.
J Am Acad Dermatol ; 82(2): 389-397, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31408686
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Talidomida / Anti-Inflamatórios não Esteroides / Inibidores da Fosfodiesterase 4 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Talidomida / Anti-Inflamatórios não Esteroides / Inibidores da Fosfodiesterase 4 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article